24 March 2026 in Quality in Sport
Background. Mental health disorders represent a major public health challenge worldwide. Depression and anxiety are among the most prevalent psychiatric conditions and are associated with substantial social and economic burden. In recent years, increasing attention has been directed toward non-pharmacological interventions supporting prevention and treatment. Physical activity has emerged as a promising strategy due to its availability, safety, and multidimensional health benefits. Aim. The aim of this study was to review current scientific literature on the impact of physical activity on mental health, with emphasis on its role in the prevention and treatment of selected mental disorders. Materials and methods. A narrative literature review was conducted using the PubMed, Scopus, and Web of Science databases. Publications examining the relationship between physical activity and mental health outcomes were analyzed. The review included randomized controlled trials, cohort studies, systematic reviews, and meta-analyses, focusing on clinical outcomes, biological and psychosocial mechanisms, and exercise-based interventions. Results. Evidence indicates that regular physical activity is associated with a reduction in symptoms of depression and anxiety and with improvements in psychological well-being. Exercise also positively influences cognitive functions such as memory, attention, and executive functioning. Proposed mechanisms include increased neurotrophic factors, modulation of neurotransmitter systems, reduced systemic inflammation, and improved self-esteem and social functioning. Conclusions. Physical activity represents an important component supporting mental health and may serve as an effective adjunct to standard treatments. Incorporating regular exercise into preventive and therapeutic programs may improve quality of life and reduce burden on healthcare systems.
28 March 2026 in Quality in Sport
Background. Technological advances in contemporary drug-eluting stents (DES) have significantly improved the safety and effectiveness of percutaneous coronary intervention (PCI). However, most studies focus on traditional clinical endpoints, while the impact of modern PCI technologies on functional recovery and return to physical activity remains less well defined. Aim. This review aimed to examine the relationship between contemporary PCI, vascular healing, and restoration of exercise capacity, with particular emphasis on cardiac rehabilitation. Material and methods. A narrative review of current literature was performed, focusing on vascular healing after PCI, endothelial recovery with newer-generation DES, thrombotic and bleeding risks during exercise, and the role of exercise-based cardiac rehabilitation. Results. Modern DES characterized by thinner struts and improved biocompatibility are associated with enhanced vascular healing and lower rates of late stent thrombosis. These features may support safer return to physical activity. However, exercise capacity depends not only on coronary patency but also on microvascular function, peripheral conditioning, and participation in rehabilitation programs. Cardiac rehabilitation plays a key role in improving fitness, quality of life, and long-term physical activity. Conclusions. Contemporary PCI provides a stable basis for safe rehabilitation and physical activity. Optimal recovery requires integration of interventional treatment with structured exercise programs and individualized management. Future studies should include standardized functional outcomes.
10 May 2026 in Quality in Sport
Background. Obesity is a complex neuroendocrine disease requiring long-term management. The emergence of GLP-1 receptor agonists has revolutionized weight loss outcomes; however, pharmacological monotherapy often leads to significant lean body mass (LBM) loss and metabolic adaptation. Aim. To analyze the clinical synergy between incretin-based pharmacotherapy and sports medicine protocols, focusing on functional tissue preservation and long-term metabolic health. Material and methods. A comprehensive review of scientific literature (2021–2026) was conducted, incorporating data from phase III clinical trials (STEP, SURMOUNT, SELECT) and exercise physiology research during pharmacological weight loss. Results. GLP-1 RA monotherapy results in LBM loss comprising 20–40% of total weight reduction. Structured resistance and aerobic training mitigates this loss, enhances muscle quality, and preserves bone mineral density. Combined therapy achieves superior visceral fat reduction and attenuates systemic inflammation while maintaining a higher basal metabolic rate compared to pharmacotherapy alone. Conclusions. Integrating sports medicine with modern pharmacotherapy represents a new standard in obesity treatment. Physical activity serves as a "metabolic anchor," preventing weight regain and improving patients' health-related quality of life (HRQoL).
13 May 2026 in Quality in Sport
Background. Axial spondyloarthritis (axSpA) is a chronic inflammatory disease affecting the spine and sacroiliac joints. In athletes, clinical identification is difficult due to symptomatic overlap with mechanical overuse and specific behavioral patterns of professional competitors. Aim. This review evaluates diagnostic hurdles of axSpA in athletes and analyzes medical management quality based on evidence from 2021–2026. Material and methods. Following SANRA guidelines, a systematic search of PubMed and Google Scholar was performed, focusing on peer-reviewed literature at the intersection of inflammatory diseases and sports medicine. Results. The athletic culture of enduring pain contributes to a diagnostic delay often exceeding seven years. Professional athletes frequently present with exercise-induced bone marrow edema on MRI, which can mimic active sacroiliitis. Effective management requires a multidisciplinary approach integrating modern pharmacotherapy with specialized physiotherapy, adhering to 2022 ASAS-EULAR recommendations and WADA regulations. Conclusions. A research gap exists regarding prospective studies in elite athletes. Improving care quality necessitates specialized screening protocols to differentiate physiological adaptations from systemic inflammation, ensuring career longevity and high quality of life.
9 June 2026 in Journal of Education, Health and Sport
Background: Colorectal cancer (CRC) is the second leading cause of cancer mortality. Modifiable factors, primarily physical inactivity, account for 70% of cases. Physical activity (PA) reduces CRC risk by 20–25%, yet precise molecular pathways require synthesis to refine prevention. Aim: To synthesize biological mechanisms of PA in CRC mitigation and evaluate optimal intensity, dose, and sedentary behavior impact for targeted recommendations. Materials and Methods: A literature review (PubMed, Scopus; 2008–2024) was conducted, integrating meta-analyses and clinical guidelines on the insulin/IGF-1 axis, myokine signaling, and gut microbiota metagenomics. Results: Four pathways were identified: 1) Metabolic: modulation of insulin/IGF-1 axis and sensitivity, 2) Immunological: reduced visceral adiposity and inflammation via myokines and NK-cell surveillance, 3) Mechanical: accelerated transit and improved bile acid metabolism, 4) Microbial: increased butyrate-producing bacteria and mucosal integrity; Protection follows a dose-response relationship, peaking at >300 min/week, especially combining aerobic and resistance training. Interrupting sedentary behavior is a critical independent factor for colonic niche health. Conclusions: PA acts as a systemic biological intervention that inhibits the initiation of neoplastic transformation. Maximum risk reduction requires multimodal training (aerobic and resistance) and the mitigation of prolonged sedentary behavior. "Precision Exercise Oncology" should prioritize individualized prescriptions based on molecular and genetic profiles.
30 June 2026 in International Journal of Innovative Technologies in Social Science
Objectives: Endometriosis is a chronic inflammatory condition affecting approximately 10% of women of reproductive age. Recent studies have highlighted vitamin D as a potential immunomodulator influencing disease progression. This review aims to synthesize current evidence regarding the mechanistic links between vitamin D and endometriosis, the correlation of serum 25(OH)D levels with disease severity, and the clinical efficacy of supplementation. Methods: A systematic literature search was conducted using PubMed and the Cochrane Library. The analysis included randomized controlled trials (RCTs), observational studies, and molecular research published within the last eight years. A qualitative narrative synthesis was performed to categorize findings into mechanistic, observational, and interventional themes. Key Findings: Molecular studies demonstrate that vitamin D inhibits endometriotic cell proliferation, inflammation, and angiogenesis by targeting the NF-κB and VEGF pathways. Observational data generally indicate lower serum 25(OH)D levels in women with advanced endometriosis compared to healthy controls. However, clinical supplementation trials yield heterogeneous results; while some RCTs report significant reductions in pelvic pain and inflammatory markers (hs-CRP), others find no statistical superiority over placebo, potentially due to variations in dosage and baseline vitamin D status. Conclusions: Vitamin D serves as a biologically plausible adjunctive therapy for endometriosis. While not a definitive cure, its safety and anti-inflammatory properties justify its use in managing deficiency. Future research should prioritize personalized supplementation protocols considering genetic polymorphisms of the vitamin D receptor.